Undifferentiated connective tissue disease laboratory findings
|
Undifferentiated connective tissue disease Microchapters |
|
Differentiating Undifferentiated connective tissue disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Undifferentiated connective tissue disease laboratory findings On the Web |
|
American Roentgen Ray Society Images of Undifferentiated connective tissue disease laboratory findings |
|
FDA on Undifferentiated connective tissue disease laboratory findings |
|
CDC on Undifferentiated connective tissue disease laboratory findings |
|
Undifferentiated connective tissue disease laboratory findings in the news |
|
Blogs on Undifferentiated connective tissue disease laboratory findings |
|
Directions to Hospitals Treating Undifferentiated connective tissue disease |
|
Risk calculators and risk factors for Undifferentiated connective tissue disease laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
Laboratory findings suggestive of undifferentiated connective tissue disease include Leukopenia,increased erythrocyte sedimentation rate, C-reactive protein, Antinuclear antibodies, anti DNA antibodies, anti Ro/SSA antibodies, and anti-RNP antibodies
Laboratory Findings
- Laboratory findings suggestive of undifferentiated connective tissue disease include:[1][2][3][4][5][6][7][8]
- Leukopenia
- Erythrocyte Sedimentation Rate
- C-Reactive Protein
- Antinuclear antibodies
- Anti DNA antibodies
- Anti Ro/SSA antibodies
- Anti-RNP antibodies
References
- ↑ Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G (1998). "Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD". Clin. Rheumatol. 17 (3): 195–201. PMID 9694051.
- ↑ Mosca M, Tani C, Neri C, Baldini C, Bombardieri S (November 2006). "Undifferentiated connective tissue diseases (UCTD)". Autoimmun Rev. 6 (1): 1–4. doi:10.1016/j.autrev.2006.03.004. PMID 17110308.
- ↑ Bodolay E, Csiki Z, Szekanecz Z, Ben T, Kiss E, Zeher M, Szücs G, Dankó K, Szegedi G (2003). "Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD)". Clin. Exp. Rheumatol. 21 (3): 313–20. PMID 12846049.
- ↑ Ceribelli A, Cavazzana I, Franceschini F, Quinzanini M, Rizzini FL, Cattaneo R (2008). "Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD)". Clin. Exp. Rheumatol. 26 (1): 117–20. PMID 18328157.
- ↑ Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S (2014). "The diagnosis and classification of undifferentiated connective tissue diseases". J. Autoimmun. 48-49: 50–2. doi:10.1016/j.jaut.2014.01.019. PMID 24518855.
- ↑ Bodolay E, Szegedi G (February 2002). "[Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy]". Orv Hetil (in Hungarian). 143 (5): 229–33. PMID 11875835.
- ↑ Cavazzana I, Franceschini F, Belfiore N, Quinzanini M, Caporali R, Calzavara-Pinton P, Bettoni L, Brucato A, Cattaneo R, Montecucco C (2001). "Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients". Clin. Exp. Rheumatol. 19 (4): 403–9. PMID 11491495.
- ↑ Laczik, R.; Soltesz, P.; Szodoray, P.; Szekanecz, Z.; Kerekes, G.; Paragh, G.; Rajnavolgyi, E.; Abel, G.; Szegedi, G.; Bodolay, E. (2014). "Impaired endothelial function in patients with undifferentiated connective tissue disease: a follow-up study". Rheumatology. 53 (11): 2035–2043. doi:10.1093/rheumatology/keu236. ISSN 1462-0324.